Comprehensive molecular docking and antifungal activity analysis of Moringa extracts targeting Candida auris dihydrofolate reductase (8CRH). [PDF]
Wizrah MSI +7 more
europepmc +1 more source
Rezafungin for Salvage or Consolidation Therapy of Invasive Fungal Disease: Experience in Real-World Clinical Practice. [PDF]
Boán J +10 more
europepmc +1 more source
Triazoles Versus Echinocandins for the First-Line Treatment of Invasive Pulmonary Aspergillosis: A Propensity Score-Weighted Multicenter Study. [PDF]
Hatzl S +9 more
europepmc +1 more source
A quiet but growing threat: Global perspectives on antifungal resistance and future therapeutic approaches. [PDF]
Gurajala S, Challapilla M.
europepmc +1 more source
Yeast infections in sterile body fluids: species distribution, antifungal susceptibility, and cross-cutting risk factors for fungemia, sepsis, and mortality (2019-2023). [PDF]
Liu J +7 more
europepmc +1 more source
Multidimensional assessment of in-host fitness costs of echinocandin resistance in the opportunistic fungal pathogen <i>Candida glabrata</i> reveals the niche-specific requirement for <i>FKS1</i> and <i>FKS2</i> during infection and gut colonization. [PDF]
Arastehfar A +9 more
europepmc +1 more source
Epidemiology, Distribution, Key Characteristics, and Challenges of Candidozyma auris (Formerly Candida auris): A Narrative Review With a Special Focus on Türkiye. [PDF]
Gökmen R, Erdoğan A, Cunetoğlu B.
europepmc +1 more source
Emergence of multidrug-resistant <i>Candidozyma auris</i> in southern China: a multicenter study on genetic diversity and antifungal resistance. [PDF]
Guo P +9 more
europepmc +1 more source
Successful outpatient parenteral antimicrobial therapy with rezafungin for chronic pulmonary aspergillosis: a case report and health economic assessment. [PDF]
Law SM +5 more
europepmc +1 more source
Emerging antifungal resistance in Candida parapsilosis: the end of the innocence. [PDF]
Guinea J +4 more
europepmc +1 more source

